2021

Eilers, W., Cleasby, M. and Foster, K. (2021) Development of antisense-mediated myostatin knockdown for the treatment of insulin resistance. Scientific Reports, 11 (1). 1604. ISSN 2045-2322 doi: https://doi.org/10.1038/s41598-021-81222-7

2020

Eilers, W., Chambers, D., Cleasby, M. and Foster, K. (2020) Local myostatin inhibition improves skeletal muscle glucose uptake in insulin resistant high fat diet-fed mice. American journal of physiology- Endocrinology and metabolism, 319 (1). E163-E174. ISSN 1522-1555 doi: https://doi.org/10.1152/ajpendo.00185.2019

Bianchi, R., Eilers, W., Pellati, F., Corsi, L., Foster, H., Foster, K. and Tamagnini, F. ORCID: https://orcid.org/0000-0002-8741-5094 (2020) Hippocampal synaptic and membrane function in the DBA/2J-mdx mouse model of Duchenne muscular dystrophy. Molecular and Cellular Neuroscience, 104. 103482. ISSN 1044-7431 doi: https://doi.org/10.1016/j.mcn.2020.103482

2017

Sutura Therapeutics LTD (2017) Biologically active compound conjugated to a stapled or stitched peptide. WO2017109494. doi: WO2017109494

2014

Cleasby, M. E., Jarmin, S., Eilers, W., Elashry, M., Andersen, D. K., Dickson, G. and Foster, K. (2014) Local overexpression of the myostatin propeptide increases glucose transporter expression and enhances skeletal muscle glucose disposal. American Journal of Physiology Endocrinol Metabolism, 306 (7). E814-E823. ISSN 1522-1555 doi: https://doi.org/10.1152/ajpendo.00586.2013